Abbott Laboratories (ABT) Raw Materials (2009 - 2026)

Abbott Laboratories has disclosed Raw Materials across 18 years of filings, most recently posting $1.8 billion for Q2 2026.

• In Q2 2026, Raw Materials rose 6.4% year-over-year to $1.8 billion; the TTM figure through Jun 2026 stood at $1.8 billion (up 6.4% YoY), while the FY2025 annual figure was $1.6 billion, down 2.78% from the prior year.
• Raw Materials came in at $1.8 billion for Q2 2026 at Abbott Laboratories, up from $1.7 billion in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $2.0 billion in Q2 2023 to a low of $1.5 billion in Q1 2022.
• Average Raw Materials over 5 years is $1.7 billion, with a median of $1.7 billion recorded in 2022.
• Year-over-year, Raw Materials rose 26.08% in 2023 and fell 10.73% in 2025.
• Over 5 years, Raw Materials stood at $1.7 billion in 2022, then climbed by 7.64% to $1.8 billion in 2023, then slipped by 8.97% to $1.7 billion in 2024, then dropped by 2.78% to $1.6 billion in 2025, then gained by 10.7% to $1.8 billion in 2026.
• Per Business Quant data, the three most recent Raw Materials figures were $1.8 billion in Q2 2026, $1.7 billion in Q1 2026, and $1.6 billion in Q4 2025.